ESMO 2023 | The role of radiotherapy in bladder preservation for patients with muscle-invasive bladder cancer

Robert A. Huddart, PhD, FRCR, MRCP, MBBS, The Institute of Cancer Research, London, UK, discusses the role of radiotherapy in bladder preservation for patients with muscle-invasive bladder cancer, delving into the patient requirements that would make them eligible for radical cystectomy evasion. This interview took place at the European Society for Medical Oncology (ESMO) 2023 Congress in Madrid, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.